Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma who Are Treated with Bortezomib-Based Therapy
Papanota, Aristea-Maria, Kastritis, Efstathios, Papassotiriou, Gerasimos-Petros, Kanellias, Nikolaos, Eleutherakis-Papaiakovou, Evangelos, Margeli, Alexandra, Migkou, Magdalini, Ntanasis-Stathopoulos,Том:
19
Мова:
english
Журнал:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.310
Date:
September, 2019
Файл:
PDF, 73 KB
english, 2019
File converter
Більше результатів пошуку
More benefits 
